Latest Zurich Stories

DURHAM, N.C., Aug. 26 /PRNewswire-FirstCall/ -- Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBO) today announced that the company will present at investor conferences in New York on Sept. 9 and Zurich on Sept. 10, 2009. Kirk Harrington, senior vice president, Warfighter Division and Government Affairs, will present at the Rodman & Renshaw Annual Global Investment Conference in New York on September 9, 2009 at 2:00 p.m. eastern time. A live, audio webcast of Harrington's...

ZURICH and ZUG, Switzerland, Aug. 7 /PRNewswire/ -- The Canton of Zug is the latest member of the Greater Zurich Area AG, the Department for Economy of the Canton of Zug and the economic promotion agency Greater Zurich Area AG announced today. Zug is sharing in the worldwide location marketing activities of Greater Zurich Area AG, joining the Swiss Cantons of Aargau, Glarus, Graubunden (Grisons), Schaffhausen, Schwyz, Solothurn, and Zurich, as well as the cities of Zurich and Winterthur....

ZURICH, July 20 /PRNewswire/ -- Nycomed today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Daxas(R) as a once-daily oral treatment for patients with symptomatic COPD. The NDA submission is based on encouraging results from four Phase III trials of Daxas(R) (roflumilast) in the treatment of symptomatic COPD. Two pivotal 12-month studies showed positive effects on exacerbation rates and pulmonary function (FEV(1)). Two supporting...

ETH Zurich is creating a new professorship in medical technology. The professorship is to develop orthopedic technologies and work closely with the research group of Schulthess Clinic Zurich. The professorship will be financed by a figure of ten million Swiss francs donated to ETH Zurich Foundation by a private foundation.The ageing of the musculoskeletal system poses major problems for doctors, surgeons and social partners: osteoporosis, arthritis, back pain and rheumatism are some of the...

ZURICH, July 16 /PRNewswire/ -- An innovative treatment for infections of the respiratory tract in cystic fibrosis patients has received a second orphan drug designation in the US only weeks after a first designation was granted. The recent designation relates to Burkholderia cepacia pathogens that can cause lethal infections in cystic fibrosis patients. For Axentis Pharma AG of Zurich, Switzerland, both designations affirm the therapeutic potential of its product candidate...

ZURICH, Switzerland, June 30 /PRNewswire/ -- DSwiss AG, the Internet data banking specialists, announced today the launch of DataInherit (http://www.datainherit.com), a new and innovative global Internet service offering a high security data safe with a unique digital inheritance feature. DataInherit provides confidential data storage in a high security Swiss data center that customers can access on-demand. Users can assign their data, entirely or in part, to multiple beneficiaries...

Direct reuse of waste heat. Aims to cut energy consumption by 40% and carbon-dioxide emissions by up to 85% ZURICH, June 23 /PRNewswire-FirstCall/ -- In an effort to achieve energy-aware computing, the Swiss Federal Institute of Technology Zurich (ETH), and IBM (NYSE: IBM) today announced plans to build a first-of-a-kind water-cooled supercomputer that will directly repurpose excess heat for the university buildings. The innovative system, dubbed Aquasar, is expected to decrease the carbon...

The future of British automaker Vauxhall appeared secure Saturday after owner General Motors agreed to sell it, observers said.Vauxhall, which employs 5,000 people at two British plants, was set to be sold to Canadian parts maker Magna International along with GM's Opel operations in Europe as the U.S. automaker agreed to a deal Friday. That was good news for Vauxhall, whose workers were anxious about their fate, The Times of London reported.British Business Secretary Peter Mandelson told...

Vienna has the highest all-round quality of life among the world's cities and Baghdad the lowest, a Canadian human resources consulting firm said Friday. Mercer, a subsidiary of Marsh & McLennon, ranked Singapore as having the best urban infrastructure. The company's annual Quality of Living Survey is aimed at helping international companies decide on overseas operations and assignments. The infrastructure ranking is new this year. Slagin Parakatil, a Mercer researcher, said companies...

ZURICH, Switzerland, April 30 /PRNewswire/ -- An innovative treatment for infections of the respiratory tract in cystic fibrosis patients has received orphan drug designation in the US. Axentis Pharma of Zurich, Switzerland announced today that this sought-after designation has been granted to its product candidate Fluidosomes-tobramycin, a therapeutic that will soon be tested in Phase II clinical trials. The company has now been granted orphan drug designation for this candidate in...